SCHEMBL20157077

SCHEMBL20157077

C=C(c1cc(CC)c(C)cc1C)N(CCC)CCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.37
HPGD P15428 1/20 0.35
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
MLYCD O95822 1/20 0.32
PGK1 P00558 1/20 0.32
PGK2 P07205 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
ESR1 P03372 1/20 0.31
CA12 O43570 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
EGFR P00533 1/20 0.30
ERBB2 P04626 1/20 0.30
APP P05067 1/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157264 0.91 TP53 (0.38) TP53HPGDGABRA1GABRB2MLYCD
SCHEMBL20156934 0.78 HPGD (0.40) TP53HPGDGABRA1GABRB2MLYCD
SCHEMBL20157023 0.73 TP53 (0.35) TP53HPGDGABRA1GABRB2MLYCD
SCHEMBL20156979 0.70 CACNA1C (0.33) HPGDPGK1PGK2NOS3NOS1
SCHEMBL20157006 0.70 MAPT (0.33) KDM4EALDH1A1MEN1CYP1A2CYP2D6
SCHEMBL18432740 0.68 NPSR1 (0.36) GABRA1GABRB2PGK1PGK2ALDH1A1
SCHEMBL20231823 0.67 PGK1 (0.50) GABRA1GABRB2PGK1PGK2ALDH1A1
SCHEMBL8282807 0.67 MLYCD (0.39) TP53HPGDMLYCDALDH1A1LMNA
SCHEMBL23252673 0.66 HSP90AA1 (0.58) HPGDGABRA1GABRB2MLYCDALDH1A1
SCHEMBL599112 0.65 NOS3 (0.44) GABRA1GABRB2PGK1PGK2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed